From “2+10” Market Saturation to Prime Time: CFU Vaping Experience Offers a New Compliance Blueprint

May.12.2025
At Vaper Expo UK, CFU Vaping Experience launched Prime 2ML, a superior alternative to traditional disposables, and Prime 10ML, a compliant solution for legal big puff. MixIn, the first smart hybrid device combining harm reduction with enhanced flavor, provides a viable option for smokers. Through technological innovation, CFU has brought sustainable solutions to the industry, leading it into a new “Prime Time.”

The UK, one of the most mature e-cigarette markets in the world, has long adopted the TPD as a key framework for product design. The core challenge lies in striking a balance between regulatory compliance and user satisfaction—a balance that defines true innovation in the industry. Disposable vapes once led the market due to their convenience and affordability, ushering in a golden era for the industry. However, as regulatory scrutiny increased, the market found itself torn between staying compliant and delivering big puff counts. Some brands pushed the boundaries of legality, while others defaulted to stacking puff counts with “2+10” formats, resulting in homogenous competition.

 

Against this backdrop, CFU Vaping Experience chose a different route: staying fully compliant without compromising on innovation. By deeply understanding consumer needs and harnessing technological advancements, CFU is redefining what compliant products can be. At the Vaper Expo UK, CFU will unveil a lineup of groundbreaking products that offer sustainable solutions, leading the industry into a new "Prime Time" of vaping.

 

From “2+10” Market Saturation to Prime Time: CFU Vaping Experience Offers a New Compliance Blueprint
CFU Vaping Experience Booth |Source:CFU Vaping Experience

 

 

Prime 2ML: Disposable Reborn, Reviving the Prime Time of Disposable Products

 

 

Disposables once flourished in the UK market due to their compact form, instant usability, and no-charge convenience. Consumers loved the ease of use; retailers appreciated the low costs, small shelf footprint, and rapid turnover.

 

With disposable bans in place, the market urgently needs a viable replacement. CFU’ s answer is Prime 2ML. This device mimics traditional disposables in size, shape, and e-liquid volume while staying fully compliant through innovative design. As CFU puts it: "Like your first vape love, but this time it lasts."

 

- Retains the beloved user experience while meeting the latest regulatory standards.
- Designed as a pod system, it’s ready to use straight out of the box—simply press the pod in place to start vaping.

- External charging module reduces device cost through unique power management.

 

From “2+10” Market Saturation to Prime Time: CFU Vaping Experience Offers a New Compliance Blueprint
Prime 2ML|Source:CFU Vaping Experience

 

Prime 10ML: New Compliant Solution for Legal Big Puff

 

 

Most so-called big puff products on the market follow a “2ML pod + 10ML refill” format, which has two major drawbacks: higher costs due to dual components and oversized devices due to stacking structures.

 

CFU's Prime 10ML offers an innovative solution by breaking away from the “2+10 model”. It adopts a novel “0+10” structure, delivering a true 10ML experience within compliance boundaries.

 

- Innovative “0+10” architecture rethinks traditional formats.
- Eliminates the 2ML pod to reduce material and assembly costs.
- Slimmer size while maintaining full 10ML capacity.

 

From “2+10” Market Saturation to Prime Time: CFU Vaping Experience Offers a New Compliance Blueprint
Prime 10ML|Source:CFU Vaping Experience

 

 

Revolutionary Satisfaction: MixIn—The World’s First Cigarette + Vape Hybrid System

 

 

At the Vaper Expo UK, CFU is making headlines with the debut of MixIn, the world’s first smart hybrid device combining harm reduction from combustible cigarettes with the flavor intensity of vapor technology. MixIn bridges the gap between traditional tobacco and vaping, offering a realistic and satisfying path for smokers transitioning to reduced-risk options.

 

- Dual experience: Reduces harmful substance intake while enriching flavor and vapor for full satisfaction.
- Customizable flavors: Choose from tobacco, fruit, mint, etc. Vape and smoke modes can be used separately or in hybrid for layered sensation.
- Enhanced vapor: Dual airflow channels maximize smoke and vapor density in hybrid mode.

 

MixIn isn’t just a feature combo—it’s a precisely engineered solution to deeply rooted user demands. Traditional smokers crave throat hit and tobacco authenticity; vape users seek variety and refinement. MixIn’s fluidic algorithms satisfy both groups with three modes and triple the satisfaction, redefining the boundaries of smoking.

 

More importantly, MixIn presents a new vision for the industry: driving harm reduction without sacrificing satisfaction, and building responsible product lines beyond just sweet flavors.

From “2+10” Market Saturation to Prime Time: CFU Vaping Experience Offers a New Compliance Blueprint
MixIn|Source:CFU Vaping Experience

 

In a time when compliance and innovation seem at odds, CFU Vaping Experience offers three game-changing products that represent more than just new formats—they redefine the industry's direction. From the compliance-oriented Prime 2ML, to the boundary-pushing Prime 10ML, and the trailblazing MixIn system, CFU stays true to one belief: real innovation is about unlocking endless possibilities within regulatory frameworks.

 

Stay engaged with CFU Vaping Experience via the following platforms:

 

We warmly invite you to join CFU Vaping Experience in exploring the new Prime Time era of the vaping industry. Stay connected with us through the following channels:

 

From “2+10” Market Saturation to Prime Time: CFU Vaping Experience Offers a New Compliance Blueprint

 

 

 

Source:First Union

Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
Alaska Warns 1,500 Tobacco Retailers Over Unauthorized Vapes and Nicotine Pouches
Alaska Warns 1,500 Tobacco Retailers Over Unauthorized Vapes and Nicotine Pouches
Alaska Attorney General Stephen J. Cox has sent notices to more than 1,500 tobacco retailers and distributors warning them against selling vape and nicotine pouch products that lack authorization from the U.S. Food and Drug Administration (FDA). According to the Alaska Department of Law, businesses were advised to verify products against FDA authorization databases and avoid selling unauthorized nicotine products. The action highlights how state-level enforcement is increasingly extending federal product authorization requirements to retail channels.
Jul.24
PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
Philip Morris International (PMI) is expanding its investment in its Golden, Colorado campus, bringing total investment to approximately $1.2 billion to support its smoke-free products business. The investment will strengthen PMI’s research, production and innovation capabilities in smoke-free products. As one of the world’s largest tobacco companies, PMI has continued advancing its “Smoke-Free Future” strategy through heated tobacco, oral nicotine and other reduced-risk product categories.
PMI
Jul.28
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
AI is moving from a back-office tool to a core organizational capability in the nicotine industry. Based on JTI’s responses, this 2Firsts feature examines how AI is reshaping talent strategy, internal mobility, decision-making and human accountability as global tobacco companies compete in the shift toward new nicotine categories.
Jun.17
Vape Vending Machine Concerns Rise in German-Speaking Europe as Schools and Age Checks Come Into Focus
Vape Vending Machine Concerns Rise in German-Speaking Europe as Schools and Age Checks Come Into Focus
Recent reports from Germany and Switzerland show growing concern over vape and tobacco vending machines near schools or in public settings, with parents, teachers and residents questioning youth access, age-verification controls and the sale of vapes alongside snacks and drinks.
Jul.06